cty

City Therapeutics IPO: What Investors Need to Know

City Therapeutics Inc. (NASDAQ: CTY) is expected to list on October 16, 2026, on the NASDAQ, with the IPO priced at $18.00 per share for 11,111,111 shares. The company has not disclosed a public price range in the calendar data, but the deal was upsized, which points to solid demand. Bull case: early clinical RNAi data and a deep platform story. Bear case: it is still pre-commercial, loss-making, and years away from proving the pipeline.